Logo image of BAKKA.OL

BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

OSL:BAKKA - Euronext Oslo - FO0000000179 - Common Stock - Currency: NOK

439.2  -4 (-0.9%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BAKKA. BAKKA was compared to 57 industry peers in the Food Products industry. BAKKA has an excellent financial health rating, but there are some minor concerns on its profitability. BAKKA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BAKKA had positive earnings in the past year.
BAKKA had a positive operating cash flow in the past year.
BAKKA had positive earnings in each of the past 5 years.
BAKKA had a positive operating cash flow in each of the past 5 years.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

BAKKA has a Return On Assets of 1.38%. This is in the lower half of the industry: BAKKA underperforms 63.16% of its industry peers.
BAKKA has a Return On Equity of 2.25%. This is in the lower half of the industry: BAKKA underperforms 66.67% of its industry peers.
BAKKA has a Return On Invested Capital (5.38%) which is in line with its industry peers.
BAKKA had an Average Return On Invested Capital over the past 3 years of 6.71%. This is in line with the industry average of 6.38%.
Industry RankSector Rank
ROA 1.38%
ROE 2.25%
ROIC 5.38%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

BAKKA has a Profit Margin (3.56%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of BAKKA has declined.
BAKKA has a better Operating Margin (16.45%) than 89.47% of its industry peers.
In the last couple of years the Operating Margin of BAKKA has declined.
BAKKA has a Gross Margin of 70.36%. This is amongst the best in the industry. BAKKA outperforms 100.00% of its industry peers.
BAKKA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.45%
PM (TTM) 3.56%
GM 70.36%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

BAKKA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BAKKA has about the same amount of shares outstanding.
The number of shares outstanding for BAKKA has been increased compared to 5 years ago.
The debt/assets ratio for BAKKA has been reduced compared to a year ago.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.83 indicates that BAKKA is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.83, BAKKA is doing good in the industry, outperforming 71.93% of the companies in the same industry.
BAKKA has a debt to FCF ratio of 3.43. This is a good value and a sign of high solvency as BAKKA would need 3.43 years to pay back of all of its debts.
The Debt to FCF ratio of BAKKA (3.43) is better than 82.46% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that BAKKA is not too dependend on debt financing.
BAKKA has a better Debt to Equity ratio (0.35) than 77.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.43
Altman-Z 2.83
ROIC/WACC0.64
WACC8.35%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BAKKA has a Current Ratio of 4.79. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BAKKA (4.79) is better than 96.49% of its industry peers.
A Quick Ratio of 1.24 indicates that BAKKA should not have too much problems paying its short term obligations.
BAKKA's Quick ratio of 1.24 is fine compared to the rest of the industry. BAKKA outperforms 75.44% of its industry peers.
Industry RankSector Rank
Current Ratio 4.79
Quick Ratio 1.24
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

BAKKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.38%.
The Earnings Per Share has been decreasing by -1.36% on average over the past years.
Looking at the last year, BAKKA shows a decrease in Revenue. The Revenue has decreased by -3.70% in the last year.
Measured over the past years, BAKKA shows a quite strong growth in Revenue. The Revenue has been growing by 10.21% on average per year.
EPS 1Y (TTM)-15.38%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-42.69%
Revenue 1Y (TTM)-3.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-13.91%

3.2 Future

BAKKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.37% yearly.
The Revenue is expected to grow by 10.85% on average over the next years. This is quite good.
EPS Next Y19.21%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue Next Year1.63%
Revenue Next 2Y10.9%
Revenue Next 3Y10.85%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

BAKKA is valuated rather expensively with a Price/Earnings ratio of 18.90.
Compared to the rest of the industry, the Price/Earnings ratio of BAKKA is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.34. BAKKA is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 9.74 indicates a reasonable valuation of BAKKA.
BAKKA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BAKKA is cheaper than 71.93% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, BAKKA is valued rather cheaply.
Industry RankSector Rank
PE 18.9
Fwd PE 9.74
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BAKKA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BAKKA is more expensive than 61.40% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BAKKA is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.48
EV/EBITDA 11.16
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

BAKKA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BAKKA's earnings are expected to grow with 26.37% in the coming years.
PEG (NY)0.98
PEG (5Y)N/A
EPS Next 2Y26.38%
EPS Next 3Y26.37%

4

5. Dividend

5.1 Amount

BAKKA has a Yearly Dividend Yield of 2.90%.
BAKKA's Dividend Yield is a higher than the industry average which is at 3.19.
Compared to an average S&P500 Dividend Yield of 2.40, BAKKA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.9%

5.2 History

The dividend of BAKKA has a limited annual growth rate of 3.15%.
Dividend Growth(5Y)3.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

206.25% of the earnings are spent on dividend by BAKKA. This is not a sustainable payout ratio.
The dividend of BAKKA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP206.25%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKAFROST P/F

OSL:BAKKA (6/18/2025, 7:00:00 PM)

439.2

-4 (-0.9%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-19 2025-05-19/bmo
Earnings (Next)08-26 2025-08-26
Inst Owners58.18%
Inst Owner ChangeN/A
Ins Owners16.05%
Ins Owner ChangeN/A
Market Cap26.08B
Analysts78.89
Price Target596.32 (35.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.9%
Yearly Dividend13.34
Dividend Growth(5Y)3.15%
DP206.25%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.76%
Min EPS beat(2)-14.72%
Max EPS beat(2)-2.8%
EPS beat(4)0
Avg EPS beat(4)-23.06%
Min EPS beat(4)-51.09%
Max EPS beat(4)-2.8%
EPS beat(8)2
Avg EPS beat(8)-15.24%
EPS beat(12)3
Avg EPS beat(12)-13.78%
EPS beat(16)3
Avg EPS beat(16)-18.56%
Revenue beat(2)0
Avg Revenue beat(2)-15.8%
Min Revenue beat(2)-18.93%
Max Revenue beat(2)-12.67%
Revenue beat(4)0
Avg Revenue beat(4)-13.13%
Min Revenue beat(4)-18.93%
Max Revenue beat(4)-8.57%
Revenue beat(8)1
Avg Revenue beat(8)-8.51%
Revenue beat(12)4
Avg Revenue beat(12)-3.86%
Revenue beat(16)6
Avg Revenue beat(16)-3.44%
PT rev (1m)-5.72%
PT rev (3m)-14.75%
EPS NQ rev (1m)-28.06%
EPS NQ rev (3m)-24.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)-10.32%
Revenue NQ rev (3m)-10.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.15%
Valuation
Industry RankSector Rank
PE 18.9
Fwd PE 9.74
P/S 2.42
P/FCF 14.48
P/OCF 7.51
P/B 1.53
P/tB 2.58
EV/EBITDA 11.16
EPS(TTM)23.24
EY5.29%
EPS(NY)45.11
Fwd EY10.27%
FCF(TTM)30.34
FCFY6.91%
OCF(TTM)58.48
OCFY13.32%
SpS181.12
BVpS286.61
TBVpS170.2
PEG (NY)0.98
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 2.25%
ROCE 6.77%
ROIC 5.38%
ROICexc 5.46%
ROICexgc 7.47%
OM 16.45%
PM (TTM) 3.56%
GM 70.36%
FCFM 16.75%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
ROICexc(3y)6.94%
ROICexc(5y)5.73%
ROICexgc(3y)9.65%
ROICexgc(5y)8.22%
ROCE(3y)8.44%
ROCE(5y)6.96%
ROICexcg growth 3Y13.09%
ROICexcg growth 5Y-10.07%
ROICexc growth 3Y16.55%
ROICexc growth 5Y-6.46%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
F-Score5
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.43
Debt/EBITDA 2.1
Cap/Depr 150.77%
Cap/Sales 15.54%
Interest Coverage 250
Cash Conversion 120.69%
Profit Quality 471.13%
Current Ratio 4.79
Quick Ratio 1.24
Altman-Z 2.83
F-Score5
WACC8.35%
ROIC/WACC0.64
Cap/Depr(3y)180.8%
Cap/Depr(5y)188.01%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-42.69%
EPS Next Y19.21%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-13.91%
Revenue Next Year1.63%
Revenue Next 2Y10.9%
Revenue Next 3Y10.85%
Revenue Next 5YN/A
EBIT growth 1Y-20.95%
EBIT growth 3Y25.01%
EBIT growth 5Y1.6%
EBIT Next Year49.17%
EBIT Next 3Y32.47%
EBIT Next 5YN/A
FCF growth 1Y222.04%
FCF growth 3Y431.02%
FCF growth 5YN/A
OCF growth 1Y39.77%
OCF growth 3Y27.94%
OCF growth 5Y17.84%